Cell-free DNA Analysis for Noninvasive Examination of Trisomy
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Cell-free DNA (cfDNA) testing for fetal trisomy is highly effective among high-risk women. However, there have been few direct, well-powered studies comparing cfDNA testing with standard screening during the first trimester in routine prenatal populations. METHODS: In this prospective, multicenter, blinded study conducted at 35 international centers, we assigned pregnant women presenting for aneuploidy screening at 10 to 14 weeks of gestation to undergo both standard screening (with measurement of nuchal translucency and biochemical analytes) and cfDNA testing. Participants received the results of standard screening; the results of cfDNA testing were blinded. Determination of the birth outcome was based on diagnostic genetic testing or newborn examination. The primary outcome was the area under the receiver-operating-characteristic curve (AUC) for trisomy 21 (Down's syndrome) with cfDNA testing versus standard screening. We also evaluated cfDNA testing and standard screening to assess the risk of trisomies 18 and 13. RESULTS: Of 18,955 women who were enrolled, results from 15,841 were available for analysis. The mean maternal age was 30.7 years, and the mean gestational age at testing was 12.5 weeks. The AUC for trisomy 21 was 0.999 for cfDNA testing and 0.958 for standard screening (P=0.001). Trisomy 21 was detected in 38 of 38 women (100%; 95% confidence interval [CI], 90.7 to 100) in the cfDNA-testing group, as compared with 30 of 38 women (78.9%; 95% CI, 62.7 to 90.4) in the standard-screening group (P=0.008). False positive rates were 0.06% (95% CI, 0.03 to 0.11) in the cfDNA group and 5.4% (95% CI, 5.1 to 5.8) in the standard-screening group (P<0.001). The positive predictive value for cfDNA testing was 80.9% (95% CI, 66.7 to 90.9), as compared with 3.4% (95% CI, 2.3 to 4.8) for standard screening (P<0.001). CONCLUSIONS: In this large, routine prenatal-screening population, cfDNA testing for trisomy 21 had higher sensitivity, a lower false positive rate, and higher positive predictive value than did standard screening with the measurement of nuchal translucency and biochemical analytes. (Funded by Ariosa Diagnostics and Perinatal Quality Foundation; NEXT ClinicalTrials.gov number, NCT01511458.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, cfDNA analysis has been useful for non-invasive prenatal testing applications, such as for the identification of trisomy 21 (ref.124).”
From Clinical metagenomics (2019) · cites this paper as [124]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
First-Trimester or Second-Trimester Screening, or Both, for Down's Syndrome
Malone, F. D., Canick, J. A., Ball, R. H., Nyberg, D. A., Comstock, C. H., Bukowski, R., Berkowitz, R. L., Gross, S. J., Dugoff, L., Craigo, S. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043693 · Cited by 1,081
Palomaki, G. E., Kloza, E. M., Lambert-Messerlian, G. M., Haddow, J. E., Neveux, L. M., Ehrich, M., van den Boom, D., Bombard, A. T., Deciu, C., Grody, W. W., et al. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e3182368a0e · Cited by 939
Gil, M. M., Quezada, M. S., Revello, R., Akolekar, R., & Nicolaides, K. H. (2015) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.14791 · Cited by 807
Akolekar, R., Beta, J., Picciarelli, G., Ogilvie, C., & D'Antonio, F. (2015) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.14636 · Cited by 711
Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population
Nicolaides, K. H., Syngelaki, A., Ashoor, G., Birdir, C., & Touzet, G. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.08.033 · Cited by 624
DNA Sequencing versus Standard Prenatal Aneuploidy Screening
Bianchi, D. W., Parker, R. L., Wentworth, J., Madankumar, R., Saffer, C., Das, A. F., Craig, J. A., Chudova, D. I., Devers, P. L., Jones, K. W., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1311037 · Cited by 620
Norton, M. E., Brar, H., Weiss, J., Karimi, A., Laurent, L. C., Caughey, A. B., Rodriguez, M. H., Williams, J., Mitchell, M. E., Adair, C. D., et al. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.05.021 · Cited by 596
Self-citationFirst-Trimester Screening for Trisomies 21 and 18
Wapner, R., Thom, E., Simpson, J. L., Pergament, E., Silver, R., Filkins, K., Platt, L., Mahoney, M., Johnson, A., Hogge, W. A., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025273 · Cited by 563
Self-citationDNA Sequencing Versus Standard Prenatal Aneuploidy Screening
Rochon, M. L. (2014) · Cited by 468
Cited by
Chiu, C. Y., & Miller, S. A. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0113-7 · Cited by 1,620
Antonarakis, S. E., Skotko, B. G., Rafii, M. S., Strydom, A., Pape, S. E., Bianchi, D. W., Sherman, S. L., & Reeves, R. H. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0143-7 · Cited by 964
Gil, M. M., Quezada, M. S., Revello, R., Akolekar, R., & Nicolaides, K. H. (2015) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.14791 · Cited by 807
Sun, K., Jiang, P., Chan, K. C. A., Wong, J., Cheng, Y. K. Y., Liang, R. H. S., Chan, W.-K., Ma, E. S. K., Chan, S. L., Cheng, S. H., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508736112 · Cited by 774
Gregg, A. R., Skotko, B. G., Benkendorf, J. L., Monaghan, K. G., Bajaj, K., Best, R. G., Klugman, S., & Watson, M. S. (2016) · Genetics in Medicine · doi:10.1038/gim.2016.97 · Cited by 683
Analysis of cell-free DNA in maternal blood in screening for aneuploidies: Updated meta-analysis
Gil, M. M., Accurti, V., Santacruz, B., Plana, M. N., & Nicolaides, K. H. (2017) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.17484 · Cited by 683
Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226
American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics, Committee on Genetics, & Society for Maternal-Fetal Medicine (2020) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000004084 · Cited by 552
Self-citationConcordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer
Wyatt, A. W., Annala, M., Aggarwal, R., Beja, K., Feng, F., Youngren, J., Foye, A., Lloyd, P., Nykter, M., Beer, T. M., et al. (2017) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djx118 · Cited by 412
Taylor-Phillips, S., Freeman, K., Geppert, J., Agbebiyi, A., Uthman, O. A., Madan, J., Clarke, A., Quenby, S., & Clarke, A. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010002 · Cited by 410
on behalf of the European Society of Human Genetics (ESHG) and the American Society of Human Genetics (ASHG), Dondorp, W., de Wert, G., Bombard, Y., Bianchi, D. W., Bergmann, C., Borry, P., Chitty, L. S., Fellmann, F., Forzano, F., et al. (2015) · European Journal of Human Genetics · doi:10.1038/ejhg.2015.57 · Cited by 349
Prenatal diagnosis by chromosomal microarray analysis
Levy, B., & Wapner, R. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.01.005 · Cited by 341
Self-citationQUADAS-C: A Tool for Assessing Risk of Bias in Comparative Diagnostic Accuracy Studies
Yang, B., Mallett, S., Takwoingi, Y., Davenport, C. F., Hyde, C. J., Whiting, P. F., Deeks, J. J., Leeflang, M. M. G., & the QUADAS-C Group† (2021) · Annals of Internal Medicine · doi:10.7326/m21-2234 · Cited by 324
Sequencing of Circulating Cell-free DNA during Pregnancy
Bianchi, D. W., & Chiu, R. W. K. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1705345 · Cited by 313
The Long and Short of Circulating Cell-Free DNA and the Ins and Outs of Molecular Diagnostics
Jiang, P., & Lo, Y. M. D. (2016) · Trends in Genetics · doi:10.1016/j.tig.2016.03.009 · Cited by 312
Advanced maternal age and adverse pregnancy outcomes
Frick, A. P. (2021) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2020.07.005 · Cited by 304
Benn, P., Borrell, A., Chiu, R. W. K., Cuckle, H., Dugoff, L., Faas, B., Gross, S., Huang, T., Johnson, J., Maymon, R., et al. (2015) · Prenatal Diagnosis · doi:10.1002/pd.4608 · Cited by 292
Self-citationIlekis, J. V., Tsilou, E., Fisher, S., Abrahams, V. M., Soares, M. J., Cross, J. C., Zamudio, S., Illsley, N. P., Myatt, L., Colvis, C., et al. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.03.001 · Cited by 292
Mackie, F., Hemming, K., Allen, S., Morris, R., & Kilby, M. (2017) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.14050 · Cited by 292
Practice Bulletin No. 163: Screening for Fetal Aneuploidy
(2016) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000001406 · Cited by 273
Zhang, J., Li, J., Saucier, J. B., Feng, Y., Jiang, Y., Sinson, J., McCombs, A. K., Schmitt, E. S., Peacock, S., Chen, S., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0334-x · Cited by 259
Self-citationGenomic Medicine–Progress, Pitfalls, and Promise
Shendure, J., Findlay, G. M., & Snyder, M. W. (2019) · Cell · doi:10.1016/j.cell.2019.02.003 · Cited by 254
Dungan, J. S., Klugman, S., Darilek, S., Malinowski, J., Akkari, Y. M. N., Monaghan, K. G., Erwin, A., & Best, R. G. (2023) · Genetics in Medicine · doi:10.1016/j.gim.2022.11.004 · Cited by 205
Prenatal and pre-implantation genetic diagnosis
Vermeesch, J. R., Voet, T., & Devriendt, K. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.97 · Cited by 192
Chan, K. C. A., Jiang, P., Sun, K., Cheng, Y. K. Y., Tong, Y. K., Cheng, S. H., Wong, A. I. C., Hudecova, I., Leung, T. Y., Chiu, R. W. K., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1615800113 · Cited by 189
Petersen, A. K., Cheung, S. W., Smith, J. L., Bi, W., Ward, P. A., Peacock, S., Braxton, A., Van Den Veyver, I. B., & Breman, A. M. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.10.005 · Cited by 175
Widschwendter, M., Zikan, M., Wahl, B., Lempiäinen, H., Paprotka, T., Evans, I., Jones, A., Ghazali, S., Reisel, D., Eichner, J., et al. (2017) · Genome Medicine · doi:10.1186/s13073-017-0500-7 · Cited by 172
Pertile, M. D., Halks-Miller, M., Flowers, N., Barbacioru, C., Kinnings, S. L., Vavrek, D., Seltzer, W. K., & Bianchi, D. W. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aan1240 · Cited by 162
Cell-free DNA for the detection of kidney allograft rejection
Aubert, O., Ursule‐Dufait, C., Brousse, R., Gueguen, J., Racapé, M., Raynaud, M., Loon, E. V., Pagliazzi, A., Huang, E., Jordan, S. C., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03087-3 · Cited by 192
Down Syndrome: Current Status, Challenges and Future Perspectives.
Kazemi, M., Salehi, M., & Kheirollahi, M. (2016) · PubMed Central · Cited by 153
Trial by Dutch laboratories for evaluation of non‐invasive prenatal testing. Part I—clinical impact
Oepkes, D., Page‐Christiaens, G. C. (., Bax, C. J., Bekker, M. N., Bilardo, C. M., Boon, E. M. J., Schuring‐Blom, G. H., Coumans, A. B. C., Faas, B. H., Galjaard, R. H., et al. (2016) · Prenatal Diagnosis · doi:10.1002/pd.4945 · Cited by 149
Chitty, L. S., Wright, D., Hill, M., Verhoef, T. I., Daley, R., Lewis, C., Mason, S., McKay, F., Jenkins, L., Howarth, A., et al. (2016) · BMJ · doi:10.1136/bmj.i3426 · Cited by 149
Stokowski, R. P., Wang, E., White, K., Batey, A., Jacobsson, B., Brar, H., Balanarasimha, M., Hollemon, D., Sparks, A. B., Nicolaides, K. H., et al. (2015) · Prenatal Diagnosis · doi:10.1002/pd.4686 · Cited by 146
Self-citationFetal fraction and noninvasive prenatal testing: What clinicians need to know
Hui, L., & Bianchi, D. W. (2019) · Prenatal Diagnosis · doi:10.1002/pd.5620 · Cited by 163
CRISPR/Cas-powered nanobiosensors for diagnostics
Phan, Q. A., Truong, L. B., Medina-Cruz, D., Dincer, C., & Mostafavi, E. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.113732 · Cited by 143
Liquid biopsy in the clinical management of hepatocellular carcinoma
von Felden, J., Garcia-Lezana, T., Schulze, K., Losic, B., & Villanueva, A. (2020) · Gut · doi:10.1136/gutjnl-2019-320282 · Cited by 141
Copy-Number Variation and False Positive Prenatal Aneuploidy Screening Results
Snyder, M. W., Simmons, L. E., Kitzman, J. O., Coe, B. P., Henson, J. M., Daza, R. M., Eichler, E. E., Shendure, J., & Gammill, H. S. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1408408 · Cited by 138
Diagnosis and prognosis of myocardial infarction on a plasmonic chip
Xu, W. L., Wang, L., Zhang, R., Sun, X., Huang, L., Su, H., Wei, X., Chen, C., Lou, J., Dai, H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15487-3 · Cited by 144
Yaron, Y. (2016) · Prenatal Diagnosis · doi:10.1002/pd.4804 · Cited by 130
Badeau, M., Lindsay, C., Blais, J., Nshimyumukiza, L., Takwoingi, Y., Langlois, S., Légaré, F., Giguère, Y., Turgeon, A. F., Witteman, W., et al. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011767.pub2 · Cited by 126
Prenatal Diagnosis Innovation: Genome Sequencing of Maternal Plasma
Wong, F. C. K., & Lo, Y. M. D. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-091014-115715 · Cited by 132
Gil, M. M., Revello, R., Poon, L. C., Akolekar, R., & Nicolaides, K. H. (2016) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.15783 · Cited by 124
Chen, Y., Yu, Q., Mao, X., Lei, W., He, M., & Lu, W. (2019) · Human Genomics · doi:10.1186/s40246-019-0250-2 · Cited by 126
Iwarsson, E., Jacobsson, B., Dagerhamn, J., Davidson, T., Bernabé, E., & Arnlind, M. H. (2016) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.13047 · Cited by 136
Self-citationLabgaa, I., Villacorta-Martin, C., D’Avola, D., Craig, A. J., von Felden, J., Martins-Filho, S. N., Sia, D., Stueck, A., Ward, S. C., Fiel, M. I., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0206-3 · Cited by 115
Pushing the limits of detection: investigation of cell-free DNA for aneuploidy screening in embryos
Ho, J. R., Arrach, N., Rhodes-Long, K., Ahmady, A., Ingles, S. A., Chung, K., Bendikson, K. A., Paulson, R. J., & McGinnis, L. K. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.03.036 · Cited by 116
Hill, M. K., Johnson, J.-A., Langlois, S. F., Lee, H. J., Winsor, S. H. M., Dineley, B., Horniachek, M., Lalatta, F., Ronzoni, L., Barrett, A. N., et al. (2015) · European Journal of Human Genetics · doi:10.1038/ejhg.2015.249 · Cited by 122
Dong, J., Chen, J., Smalley, M. D., Zhao, M., Ke, Z., Zhu, Y., & Tseng, H. (2019) · Advanced Materials · doi:10.1002/adma.201903663 · Cited by 111
Schuurman, L. V. P., Sistermans, E. A., Opstal, D. V., Henneman, L., Bekker, M. N., Bax, C. J., Pieters, M. J., Bouman, K., de Munnik, S., den Hollander, N. S., et al. (2022) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2022.04.018 · Cited by 108
Non-Invasive Prenatal Testing (NIPT): Reliability, Challenges, and Future Directions
Jayashankar, S. S., Nasaruddin, M. L., Hassan, M. F., Dasrilsyah, R. A., Shafiee, M. N., Ismail, N. A. S., & Alias, E. (2023) · Diagnostics · doi:10.3390/diagnostics13152570 · Cited by 148
on behalf of the European Society of Human Reproduction and Embryology and European Society of Human Genetics, Harper, J. C., Aittomäki, K., Borry, P., Cornel, M. C., de Wert, G. M. W. R., Dondorp, W., Geraedts, J. P. M., Gianaroli, L., Ketterson, K., et al. (2017) · European Journal of Human Genetics · doi:10.1038/s41431-017-0016-z · Cited by 125
Noninvasive prenatal screening for fetal common sex chromosome aneuploidies from maternal blood
Zhang, B., Lu, B., Yu, B., Zheng, F., Zhou, Q., Chen, Y.-P., & Zhang, X. (2017) · Journal of International Medical Research · doi:10.1177/0300060517695008 · Cited by 99
Ordulu, Z., Kammin, T., Brand, H., Pillalamarri, V., Redin, C. E., Collins, R. L., Blumenthal, I., Hanscom, C., Pereira, S., Bradley, I., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.08.022 · Cited by 100
Gögenur, M., Burcharth, J., & Gögenür, I. (2017) · Critical Care · doi:10.1186/s13054-016-1578-9 · Cited by 97
Johansson, Å., Andreassen, O. A., Brunak, S., Franks, P. W., Hedman, H., Loos, R. J. F., Meder, B., Melén, E., Wheelock, C. E., & Jacobsson, B. (2023) · Journal of Internal Medicine · doi:10.1111/joim.13640 · Cited by 127
Self-citationKozlowski, P., Burkhardt, T., Gembruch, U., Gonser, M., Kähler, C., Kagan, K. O., von Kaisenberg, C., Klaritsch, P., Merz, E., Steiner, H., et al. (2018) · Ultraschall in der Medizin - European Journal of Ultrasound · doi:10.1055/a-0631-8898 · Cited by 96
Sequencing Newborns:A Call for Nuanced Use of Genomic Technologies
Johnston, J., Lantos, J. D., Goldenberg, A. J., Chen, F., Parens, E., Koenig, B. A., & members of the NSIGHT Ethics and Policy Advisory Board (2018) · The Hastings Center Report · doi:10.1002/hast.874 · Cited by 133
Lewis, C., Hill, M., & Chitty, L. S. (2016) · PLOS ONE · doi:10.1371/journal.pone.0153147 · Cited by 85
Screening for fetal aneuploidy
Rink, B. D., & Norton, M. E. (2015) · Seminars in Perinatology · doi:10.1053/j.semperi.2015.11.006 · Cited by 93
Self-citationGrati, F. R. (2016) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.15975 · Cited by 86
Mital, S. R., Musunuru, K., Garg, V., Russell, M. W. W., Lanfear, D. E., Gupta, R. M., Hickey, K. T., Ackerman, M. J., Perez, M. V., Roden, D. M., et al. (2016) · Circulation Cardiovascular Genetics · doi:10.1161/hcg.0000000000000031 · Cited by 89
Liquid Biopsy Based on Cell-Free DNA and RNA
Loy, C., Ahmann, L. S., Vlaminck, I. D., & Gu, W. (2024) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-110222-111259 · Cited by 93
Hu, H., Wang, L., Wu, J., Zhou, P., Fu, J., Sun, J., Cai, W., Liu, H., & Yang, Y. (2019) · Human Genomics · doi:10.1186/s40246-019-0198-2 · Cited by 87
Review of the immune mechanisms of preeclampsia and the potential of immune modulating therapy
Collier, A.-R. Y., Smith, L. A., & Karumanchi, S. A. (2021) · Human Immunology · doi:10.1016/j.humimm.2021.01.004 · Cited by 109
Global burden of genetic disease and the role of genetic screening
Verma, I. C., & Puri, R. D. (2015) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2015.07.002 · Cited by 95
Chitty, L. S., & Lo, Y. M. D. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a023085 · Cited by 94
Factors affecting cell-free DNA fetal fraction and the consequences for test accuracy
Scott, F., Menezes, M. A., Palma-Dias, R. S., Nisbet, D., Schlüter, P. J., Costa, F. D. S., & McLennan, A. (2017) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2017.1330881 · Cited by 81
Sachs, A., Blanchard, L., Buchanan, A., Norwitz, E. R., & Bianchi, D. W. (2015) · Prenatal Diagnosis · doi:10.1002/pd.4666 · Cited by 92
Cell-free DNA vs sequential screening for the detection of fetal chromosomal abnormalities
Norton, M. E., Baer, R. J., Wapner, R. J., Kuppermann, M., Jelliffe‐Pawlowski, L. L., & Currier, R. J. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.12.018 · Cited by 78
Self-citationTaneja, P. A., Snyder, H. L., de Feo, E., Kruglyak, K. M., Halks‐Miller, M., Curnow, K. J., & Bhatt, S. (2015) · Prenatal Diagnosis · doi:10.1002/pd.4766 · Cited by 78
Cell-free DNA Analysis for Noninvasive Examination of Trisomy.
Sentilhes, L., Salomon, L., & Vayssière, C. (2015) · PubMed · doi:10.1056/nejmc1509344 · Cited by 29
Self-citationvan Schendel, R. V., van El, C. G., Pajkrt, E., Henneman, L., & Cornel, M. C. (2017) · BMC Health Services Research · doi:10.1186/s12913-017-2618-0 · Cited by 83
Bedei, I. A., Wolter, A., Weber, A., Signore, F., & Axt-Fliedner, R. (2021) · Genes · doi:10.3390/genes12040501 · Cited by 91
Shaw, J., Scotchman, E., Chandler, N. J., & Chitty, L. S. (2020) · Reproduction · doi:10.1530/rep-19-0591 · Cited by 87
Fleiss, B., Wong, F., Brownfoot, F., Shearer, I. K., Baud, O., Walker, D. W., Gressens, P., & Tolcos, M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00188 · Cited by 74
Cell-free DNA screening for prenatal detection of 22q11.2 deletion syndrome
Dar, P., Jacobsson, B., Clifton, R. G., Egbert, M., Malone, F. D., Wapner, R. J., Roman, A. S., Khalil, A. A., Faro, R., Madankumar, R., et al. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2022.01.002 · Cited by 85
Self-citationRecent advances in prenatal genetic screening and testing
den Veyver, I. B. V. (2016) · F1000Research · doi:10.12688/f1000research.9215.1 · Cited by 80
Hou, S., Chen, J., Song, M., Zhu, Y., Jan, Y. J., Chen, S. H., Weng, T.-H., Ling, D., Chen, S., Ro, T., et al. (2017) · ACS Nano · doi:10.1021/acsnano.7b03073 · Cited by 78
Factors Affecting the Fetal Fraction in Noninvasive Prenatal Screening: A Review
Deng, C., & Liu, S. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.812781 · Cited by 80
van Schendel, R. V., Christiaens, G. C. M. L., Beulen, L., Bilardo, C. M., de Boer, M. A., Coumans, A. B. C., Faas, B. H. W., van Langen, I. M., Lichtenbelt, K. D., van Maarle, M. C., et al. (2016) · Prenatal Diagnosis · doi:10.1002/pd.4941 · Cited by 86
Hill, M. K., Barrett, A. N., Choolani, M. A., Lewis, C., Fisher, J., & Chitty, L. S. (2017) · Prenatal Diagnosis · doi:10.1002/pd.5182 · Cited by 71
Vecchio, G. D., Li, Q., Li, W., Thamotharan, S., Tosevska, A., Morselli, M., Sung, K., Janzen, C., Zhou, X. J., Pellegrini, M. A., et al. (2020) · Epigenetics · doi:10.1080/15592294.2020.1816774 · Cited by 82
Bioinformatics Approaches for Fetal DNA Fraction Estimation in Noninvasive Prenatal Testing
Peng, X. L., & Jiang, P. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020453 · Cited by 74
Malan, V., Bussières, L., Winer, N., Jaïs, J., Baptiste, A., Lorc’h, M. L., Elie, C., O’Gorman, N., Fries, N., Houfflin‐Debarge, V., et al. (2018) · JAMA · doi:10.1001/jama.2018.9396 · Cited by 79
What Do Parents of Children with Down Syndrome Think about Non‐Invasive Prenatal Testing (NIPT)?
van Schendel, R. V., Kater‐Kuipers, A., van Vliet‐Lachotzki, E. H., Dondorp, W., Cornel, M. C., & Henneman, L. (2016) · Journal of Genetic Counseling · doi:10.1007/s10897-016-0012-4 · Cited by 84
Liquid Biopsy: From Basic Research to Clinical Practice
Macías, M., Alegre, E., Díaz‐Lagares, Á., Patiño‐García, A., Perez‐Gracia, J. L., Sanmamed, M. F., López‐López, R., Varo, N., & González, Á. (2017) · Advances in clinical chemistry · doi:10.1016/bs.acc.2017.10.003 · Cited by 78
Causes of aberrant non-invasive prenatal testing for aneuploidy: A systematic review
Samura, O., & Okamoto, A. (2020) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2019.11.003 · Cited by 68
Fetal cell-free DNA fraction in maternal plasma is affected by fetal trisomy
Suzumori, N., Ebara, T., Yamada, T., Samura, O., Yotsumoto, J., Nishiyama, M., Miura, K., Sawai, H., Murotsuki, J., Kitagawa, M., et al. (2016) · Journal of Human Genetics · doi:10.1038/jhg.2016.25 · Cited by 66
Dar, P., Jacobsson, B., MacPherson, C., Egbert, M., Malone, F. D., Wapner, R. J., Roman, A. S., Khalil, A. A., Faro, R., Madankumar, R., et al. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2022.01.019 · Cited by 70
Self-citationBurns, W. R., Koelper, N., Barberio, A., Deagostino‐Kelly, M., Mennuti, M. T., Sammel, M. D., & Dugoff, L. (2017) · Prenatal Diagnosis · doi:10.1002/pd.5152 · Cited by 73
Gerson, K. D., Truong, S., Haviland, M. J., O’Brien, B. M., Hacker, M. R., & Spiel, M. H. (2019) · Pregnancy Hypertension · doi:10.1016/j.preghy.2019.04.002 · Cited by 70
Fetal postmortem imaging: an overview of current techniques and future perspectives
Kang, X., Carlin, A., Cannie, M., Sanchez, T. C., & Jani, J. C. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.04.034 · Cited by 73
Prospective prenatal cell-free DNA screening for genetic conditions of heterogenous etiologies
Zhang, J., Wu, Y., Chen, S., Luo, Q., Xi, H., Li, J., Qin, X., Peng, Y., Ma, N., Yang, B. X., et al. (2024) · Nature Medicine · doi:10.1038/s41591-023-02774-x · Cited by 73
Noninvasive prenatal testing for fetal aneuploidy and single gene disorders
Skrzypek, H., & Hui, L. (2017) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2017.02.007 · Cited by 75
Hutchinson, J. C., Kang, X., Shelmerdine, S. C., Segers, V., Lombardi, C. M., Cannie, M., Sebire, N. J., Jani, J. C., & Arthurs, O. J. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.01.040 · Cited by 69
Tsao, D., Silas, S., Landry, B. P., Itzep, N. P., Nguyen, A. B., Greenberg, S., Kanne, C. K., Sheehan, V., Sharma, R., Shukla, R., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-50378-8 · Cited by 67
Fairbrother, G. L., Burigo, J., Sharon, T., & Song, K. (2015) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2015.1038703 · Cited by 62
Sherwood, K. R., & Weimer, E. T. (2018) · Journal of Immunological Methods · doi:10.1016/j.jim.2018.09.011 · Cited by 67
Genome-wide cfDNA screening: clinical laboratory experience with the first 10,000 cases
Ehrich, M., Tynan, J. A., Mazloom, A. R., Almasri, E., McCullough, R. M., Boomer, T., Grosu, D. S., & Chibuk, J. (2017) · Genetics in Medicine · doi:10.1038/gim.2017.56 · Cited by 62
Xu, L., Huang, H., Lin, N., Wang, Y., He, D., Zhang, M., Chen, M., Chen, L., & Lin, Y. (2019) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.20416 · Cited by 61
Tan, Y., Gao, Y. M., Lin, G., Fu, M., Li, X., Yin, X., Du, J., Li, J., Li, W., Peng, H., et al. (2016) · Prenatal Diagnosis · doi:10.1002/pd.4837 · Cited by 59
Metadata
- Authors
- Norton, M. E., Jacobsson, B., Swamy, G. K., Laurent, L. C., Ranzini, A. C., Brar, H., Tomlinson, M. W., Pereira, L., Spitz, J. L., Hollemon, D., Cuckle, H., Musci, T. J., & Wapner, R. J.
- Affiliations
- Saint Peter's University Hospital (US)
- Sahlgrenska University Hospital (SE)
- Duke University (US)
- University of California San Diego (US)
- Oregon Health & Science University (US)
- Perinatal Quality Foundation (US)
- Columbia University (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-04-23
- Volume
- 372
- Issue
- 17
- Pages
- 1589-1597
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2139926668
- Cited by
- 817
- References
- 32
- Citations by year
- 2026: 33 · 2025: 39 · 2024: 50 · 2023: 59 · 2022: 61 · 2021: 86 · 2020: 72 · 2019: 74 · 2018: 73 · 2017: 86 · 2016: 107 · 2015: 75
- FWCI
- 113.51
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Västra Götalandsregionen
- Thomas Jefferson University
- University of California, San Diego
- University of California, San Francisco
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Screening and Diagnostics
- Health Sciences › Medicine › Obstetrics and Gynecology › Maternal and Perinatal Health Interventions
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Assisted Reproductive Technology and Twin Pregnancy
- Keywords
- cell-free DNA, prenatal aneuploidy screening, Down syndrome, trisomy 18, trisomy 13, first-trimester screening, nuchal translucency, biochemical analytes, diagnostic accuracy, false positive rate, positive predictive value, non-invasive prenatal testing, maternal age
- MeSH terms
- Adolescent, Adult, Chromosome Aberrations, DNA, Down Syndrome, False Positive Reactions, Female, Fetus, Humans, Middle Aged, Pregnancy, Pregnancy Trimester, First, Prenatal Diagnosis, Prospective Studies, Sensitivity and Specificity, Single-Blind Method, Area Under Curve, Nuchal Translucency Measurement, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.